BIOXEL ACHIEVES KEY MILESTONE IN MANUFACTURING OF DOCETAXEL

Bioxel Pharma Inc., a leading manufacturer and supplier of taxane APIs and developer of targeted oncology drugs, is pleased to announce manufacturing of the first industrial scale cGMP batch of its key intermediate for docetaxel.

BioSpace (http://www.marketwire.com/mw/release_html_pressroom?id=F65B254181F3F030&release_id=163470)